Schedule 13G ownership disclosure

VITAE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 92847N103

Event date: 2016-08-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,119,036
Percent of class
7.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-16-119488
Form type
SC 13G
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Aug 15, 2016
Reporting period
Aug 05, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub